DMT-2′O-TBDMS-rU-6-13C,5-d phosphoramidite
|
|
- $715 - $2080
- Product name: DMT-2′O-TBDMS-rU-6-13C,5-d phosphoramidite
- CAS:
- MF:
- MW: 0
- EINECS:
- MDL Number:
- Synonyms:DMT-2′O-TBDMS-rU-6-13C,5-d phosphoramidite
4 prices
Selected condition:
Brand
- Sigma-Aldrich
Package
- 10mg
- 50mg
- 10 mg
- 50 mg
- ManufacturerSigma-Aldrich
- Product number904597
- Product descriptionDMT-2′O-TBDMS-rU-6-13C,5-d phosphoramidite ≥98 atom % D, ≥98 atom % 13C, ≥95% (CP)
- Packaging10mg
- Price$715
- Updated2024-03-01
- Buy
- ManufacturerSigma-Aldrich
- Product number904597
- Product descriptionDMT-2′O-TBDMS-rU-6-13C,5-d phosphoramidite ≥98 atom % D, ≥98 atom % 13C, ≥95% (CP)
- Packaging10 mg
- Price$747
- Updated2025-07-31
- Buy
- ManufacturerSigma-Aldrich
- Product number904597
- Product descriptionDMT-2′O-TBDMS-rU-6-13C,5-d phosphoramidite ≥98 atom % D, ≥98 atom % 13C, ≥95% (CP)
- Packaging50 mg
- Price$1790.25
- Updated2025-07-31
- Buy
- ManufacturerSigma-Aldrich
- Product number904597
- Product descriptionDMT-2′O-TBDMS-rU-6-13C,5-d phosphoramidite ≥98 atom % D, ≥98 atom % 13C, ≥95% (CP)
- Packaging50mg
- Price$2080
- Updated2024-03-01
- Buy
| Manufacturer | Product number | Product description | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|
| Sigma-Aldrich | 904597 | DMT-2′O-TBDMS-rU-6-13C,5-d phosphoramidite ≥98 atom % D, ≥98 atom % 13C, ≥95% (CP) | 10mg | $715 | 2024-03-01 | Buy |
| Sigma-Aldrich | 904597 | DMT-2′O-TBDMS-rU-6-13C,5-d phosphoramidite ≥98 atom % D, ≥98 atom % 13C, ≥95% (CP) | 10 mg | $747 | 2025-07-31 | Buy |
| Sigma-Aldrich | 904597 | DMT-2′O-TBDMS-rU-6-13C,5-d phosphoramidite ≥98 atom % D, ≥98 atom % 13C, ≥95% (CP) | 50 mg | $1790.25 | 2025-07-31 | Buy |
| Sigma-Aldrich | 904597 | DMT-2′O-TBDMS-rU-6-13C,5-d phosphoramidite ≥98 atom % D, ≥98 atom % 13C, ≥95% (CP) | 50mg | $2080 | 2024-03-01 | Buy |
Properties
storage temp. :-20°C
form :powder
form :powder
Safety Information
| Symbol(GHS): | ||||||||
|---|---|---|---|---|---|---|---|---|
| Signal word: | ||||||||
| Hazard statements: |
|
|||||||
| Precautionary statements: |
|




